Lenz & Staehelin‘s ’technically brilliant’ team is well-equipped to handle the full gamut of issues arising across the biotech, medical device, diagnostics, and pharma industries. Zurich’s Thierry Calame is hailed by clients as an ‘adept and careful litigator’, and is well-known for his strength in unfair competition and copyright litigation, with a strong emphasis on IP-focused arbitrations, and disputes specialist Harold Frey routinely acts in international arbitrations and domestic proceedings involving joint ventures and licensing issues. In the Geneva office, Xavier Favre-Bulle is noted for his longstanding expertise in arbitrations concerning licences and post M&A issues, while Andreas Rötheli, who also leads the firm’s corporate and M&A group, often advises on private equity buyouts and real estate transactions.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘Hardworking, available and capable of thinking outside the box.’

  • ‘Peter Ling - hardworking, always available and a creative thinker.’

  • ‘Technically brilliant, focused, very efficient.’

  • ‘Extremely responsive - fast turnaround times, very pleasant interactions.’

  • ‘Thierry Calame is an adept and careful litigator, a must-have in any international team. ’

  • ‘Very good at working with international teams on global disputes.’

  • ‘Sophisticated, professional, available, and exceptional business knowledge.’

  • ‘Peter Ling is a top-notch lawyer, always looking for excellence in every assignment.’

Key clients

  • Abbott Laboratories
  • Acino
  • Alcon
  • Alpha Health Group
  • Altitude Managemen
  • Asceneuron
  • Bain Capital Private Equity
  • Cinven
  • Chord Therapeutics
  • Dacadoo
  • Ferring
  • Gyrus Capital
  • Hasten Biopharmaceutic Co., Ltd (China)
  • Keri Medical
  • Lonza
  • Manufacture Modules Technologies
  • Owners of the Ardentis group
  • Mepha
  • Merck & Co., Inc.
  • Morgan Stanley
  • MGI Tech, Ltd.
  • MSD
  • NovImmune
  • Obseva
  • Pfizer
  • Revance Therapeutics, Inc.
  • Surveyor Capital
  • swiss smile Schweiz AG
  • Teva
  • The Carlyle Group
  • Unilabs
  • Wyss Center

Work highlights

  • Represented MSD before the Federal Patent Court in an SPC infringement case, resulting in an ex parte injunction regarding the sale of a generic fixed-dose combination of sitagliptin and metformin which was later confirmed by a panel of three judges.
  • Advising the Wyss Center for Bio and Neuro Engineering, a neurosciences research institution based in Geneva, on all areas of law to support its activities, and also those of the startups hosted at the centre.
  • Advised a group of investors led by SME Equity Partners and Co-Investor Partners on the acquisition of Promedical AG, a Swiss supplier of medical consumables and surgery kits.

Practice head

The lawyer(s) leading their teams.

Thierry Calame, Stephan Erni, Harold Frey, Xavier Favre-Bulle, Andreas Rötheli, Guy Vermeil

Other key lawyers

Peter Ling